|
| Exchange Received Time 26/03/2025 19:59:17 Exchange Disseminated Time 26/03/2025 19:59:19 Time Taken 00:00:02 | | Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 29, 2025, inter alia, to consider and approve Audited Financial Statements for the Financial Year ended March 31, 2025 and to consider recommendation of dividend (if any). |
|
|